novel agents in the metastatic colorectal cancer refractory setting
Published 8 years ago • 506 plays • Length 7:11Download video MP4
Download video MP3
Similar videos
-
22:10
novel agents and targets in colorectal cancer
-
6:42
novel therapies in development for metastatic colorectal cancer
-
4:58
tas-102 in refractory metastatic colorectal cancer
-
6:54
treatment approach in colorectal cancer refractory setting
-
7:31
sequencing agents in metastatic colorectal cancer
-
5:20
foods that prevent polyps in the colon
-
20:52
what is the optimal therapy for braf mutant metastatic colorectal cancer?
-
35:42
immunotherapy in crc | 2023 best of gi cancer conference
-
6:01
new drugs in development for metastatic colorectal cancer
-
5:54
initial systemic therapy for metastatic colorectal cancer
-
1:48
dr. grothey discusses novel agents for colorectal cancer
-
13:11
treatment sequencing in metastatic colorectal cancer
-
5:35
emerging therapy in metastatic colorectal cancer
-
7:17
exploring results of the sunlight trial in metastatic colorectal cancer: josep tabernero, md, phd
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
23:09
colorectal cancer: updates on novel agents and targets
-
8:45
colorectal cancer: refractory disease
-
7:32
treatment options in refractory mcrc
-
3:43
goals of therapy in refractory colorectal cancer
-
3:59
liver-directed therapies in metastatic colorectal cancer
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
9:52
chemotherapy for metastatic colorectal cancer in 2017